硫酸镁治疗妊高征对新生儿Apgar评分的影响  

Effect of magnesium sulfate on neonte Apgar score in the treatment of pregnancy-induced hypertension

作　　者：孙艳艳[1] 刘源[1] 杜思爱 

机构地区：[1]山西医科大学第一临床医学院,山西太原030001

出　　处：《山西临床医药》2001年第4期258-259,共2页Shanxi Clinical Medicine

摘　　要：目的 :了解妊高征孕妇产前接受硫酸镁治疗与新生儿 Apgar评分之间的关系。方法 :收集 1992年～ 1995年期间住院分娩的 12 0名妊高征患者 ,按轻、中、重度分 ,将其中 86例中、重度妊高征患者 ,按其有无接受硫酸镁治疗分为硫酸镁治疗组与对照组 ,分析两组新生儿窒息发生的情况。结果 :硫酸镁治疗组新生儿窒息发生率明显低于对照组(P<0 .0 5 ) ,差异有统计学意义。结论 :新生儿窒息发生率低与妊高征产前接受硫酸镁治疗有关 ,提示硫酸镁对胎儿缺氧有保护作用 ,可以防止或减轻新生儿缺氧状况。Objective:To study the relation between in utero exposure to magnesium sulfate and neonate Apgar score.Methods:All hospitalized case with pregnancy induced hypertension(120) was classified by different severity during 1992～1995 in our hospital,86 of which with moderate or severe pregnancy-induced hypertension were divided into two groups according to in utero exposure to magnesium sulfate or not:treatment group and control group,and then analyze neonate Apgar score of two groups.Resluts:The percentages of asphxia of newborn from treatment group are lower than those of control( P <0.05) and there was a significent difference between these two groups.Conclusion:In utero exposure to magnesium sulfate is associated with lower percentage of asphxia of newborm.It suggests that magnesium sulfate has a protective effect on fetus brain hypoxia and prevent from hypoxia of newborn or reduce severity of hypoxia.

关 键 词：硫酸镁 新生儿窒息 妊娠高血压综合征 APGAR评分 

分 类 号：R714.246[医药卫生—妇产科学] R722.12[医药卫生—临床医学]